The global pediatric interventional cardiology market reached a value of US$ 2.28 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.46 Billion by 2027, exhibiting a CAGR of 6.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Pediatric interventional cardiology is a subset of cardiology that involves the use of specific catheter-based techniques to treat heart disorders in infants, children, and adolescents upto 18 years of age. They include balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis. As compared to conventional cardiological treatments, pediatric interventional cardiology is more minimally invasive, thus reducing post-surgerycomplications. Consequently, they are extensively employed for performing angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect correction procedures across clinical testing laboratories, hospitals, cardiac centers, and research institutes.

Pediatric Interventional Cardiology Market Trends:
Theincreasing instances of various congenital cardiac diseases in children, such as atrial septal defect (ASD), atrioventricular canal defect, patent ductus arteriosus (PDA), and ventricular septal defect (VSD) represent one of the key factors driving the pediatric interventional cardiology market growth. The introduction of novel and more efficient pediatric interventional cardiology devices, including catheters, bio-absorbable stents, guidewires, balloons, stents, vascular closure devices, atherectomy devices is acting as another major growth-inducing factor.In line with this, the shifting inclination of patients toward non-invasive medical treatment procedures, along with the rising awareness regarding the associated benefits, such as lower risk of infection, shorter postoperative recovery times, and avoidance of large scars is also driving the market growth. Other factors, including rising healthcare expenditure and the numerous initiatives being undertaken by governments of various nations to speed-up regulatory procedures, are creating a positive outlook for the market. The market is also driven by extensive research and development (R&D) activities, increasing consumer healthcare expenditure and investments by governments and non-government organizations (NGOs) for strengthening the existing healthcare infrastructure, and significant technological advancements in the field of cardiology.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pediatric interventional cardiology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on device type, procedure and end use.

Breakup by Device Type:

Closure Devices
Transcatheter Heart Valves
Atherectomy Devices
Catheters
Balloons
Stents
Others

Breakup by Procedure:

Catheter-Based Valve Implantation
Congenital Heart Defect Correction
Angioplasty
Coronary Thrombectomy
Others

Breakup by End Use:

Clinical Testing Laboratories
Hospitals
Cardiac Centers
Pediatric Clinics
Research Institutions

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc. Key Questions Answered in This Report:
How has the global pediatric interventional cardiology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pediatric interventional cardiology market?
What are the key regional markets?
What is the breakup of the market based on the device type?
What is the breakup of the market based on the procedure?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pediatric interventional cardiology market and who are the key players?
What is the degree of competition in the industry?